Iridex
Company   Investors   Find a Physician   News   Careers   Germany   Search
Sales: 650.962.8100    Support: 800.388.4747
Facebook  Twitter  LinkedIn  YouTube  Instagram
  • Home
  • Products
    • Lasers
      • Cyclo G6
      • OcuLight
      • IQ 532
      • IQ 577
    • Retinal Surgical Instruments
      • Laser Probes
      • Consumables
    • Veterinary
    • Retina Delivery Devices
      • LIO
      • TxCell
    • Glaucoma Devices
      • MicroPulse P3 Device
      • Revised MicroPulse P3
      • G-Probe
      • G-Probe Illuminate
      • MicroPulse Laser Trabeculoplasty (MLT) Lens
    • ENT
    • Accessories
      • Vexio Cart
  • MicroPulse
  • PASCAL®
    • Iridex PASCAL ®
    • PASCAL® Synthesis
  • Physician Education
    • Glaucoma
      • Library
      • MicroPulse P3 - CYCLO G6
      • TSCPC G-Probe
    • Retina
      • Age-Related Macular Degeneration
      • Central Serous Chorioretinopathy
      • Diabetic Macular Edema
      • ME due to RVOs
      • ROP
      • Vitreoretinal Surgery
    • Testimonials
    • Certification
    • Webinars
    • Seminars
    • Articles
    • Manuals
  • Patient Education
    • Treat My DME
    • Treat My Glaucoma
    • Understanding ROP
    • Find A Physician
  • Contact
    • Contact Us
    • Ask A Question
    • Ask Tech Support
    • Schedule A Demo
    • Request A Quote
    • International Distributors
HOME > Products > Lasers > IQ 532 ...

IQ 532® Laser System – Dual port green laser for comprehensive ophthalmology.

MicroPulse® Laser Therapy for repeatable, tissue-sparing* glaucoma and retinal therapies.

532 laser PRODUCT HIGHLIGHTS

  • High power for greater range of therapy alternatives
  • Dual port for efficient setup of alternate delivery devices
  • Repeatable laser sessions for retinal diseases with optional MicroPulse module

Download Brochure


Download The Retina Portfolio Brochure



Schedule a hands-on demo

Schedule a no-obligation demo to see for yourself how MicroPulse Technology and Iridex’s Family of Products can take YOUR practice to the next level.

Schedule a demo

Schedule a demo today!

×
  • Overview
  • Specifications
  • Product Videos
  • Clinical
  • Accessories
  • Testimonials
  • News

The Advantages of Innovation

  • High power for greater range of therapy alternatives
  • High speed pulse durations for faster procedural time
  • DualSense provides quick and simple selection of multiple delivery devices for RFID and SMA

Intelligent and intuitive design

  • Dual Port for efficient setup of alternate delivery devices
  • Intuitive graphic touch screen interface for ease of use
  • Programmable memory presets for multiple users

Optional Module for MicroPulse Laser Therapy, Fovea-Friendly*

  • Repeatable laser sessions for retinal diseases
  • Repeatable glaucoma therapy with MicroPulse laser trabeculoplasty (MLT)


 

IQ577 / IQ532 Operator Manuals

View Manuals

IQ 532® Laser System

 
Wavelength 532 nm Green
Weight 19.2 lb (9.0 kg)
Dimensions 8.5" H x 12" W x 14" D
(21 cm x 30 cm x 35 cm)
Connector Type
RFID | Resistor
Electrical 100-240 VAC, 50/60 Hz
Cooling Whisper fan
Exposure Duration CW-Pulse: 10-3000 ms
Exposure Interval CW-Pulse: 10-3000 ms
MicroPulse Duration MicroPulse: 0.05-1.00 ms
MicroPulse Interval MicroPulse: 1.00-10.00 ms
Aiming Laser Diode laser, 635 nm nominal
Delivery Device Power Output Portable SLA: 0-2000 mW
LIO: 0-2000 mW
EndoProbe: 0-2000 mW

IQ 532 Laser Product Video

 

 

CombiningTissue-sparingMicroPulseTM LaserTherapyand Anti-VEGF Medication Produces Unprecedented Results in Radiation Retinopathy

MicroPulse is a laser energy delivery modality that enables fine control of the thermal effects of photoco- agulation...

pdf Download Now

 

MicroPulse™ Case Report - Diabetic Macular Edema

Iridex has set the standard for probe technology, meeting surgical needs for small-gauge probes that consistently and accurately deliver laser treatment at a safe distance from the retina, without sacrificing illumination.

pdf Download Now

 

532 nm Subthreshold MicroPulse Effectively Reduces Diabetic Macular Edema after Failed Conventional Laser Treatment

Iridex has set the standard for probe technology, meeting surgical needs for small-gauge probes that consistently and accurately deliver laser treatment at a safe distance from the retina, without sacrificing illumination.

pdf Download Now

Optional Accessories

Full-Featured Remote Control

  • Compact design for easy placement or use in sterile field
  • View displays and adjust parameters from two vantage points for increased convenience and efficiency

Wireless Footswitch

  • No cord, no clutter, no limitations
  • Allows precise physician control over power settings
  • Available with power-adjust to control laser actuation and power settings

Munir Escaf, MD

Retina Specialist
Clinica Carriazo Barranquilla
Atlantico, Columbia

Jonathan Feistman, MD

Retina Specialist
NYC Retina
New York City, NY

Brian Horsman, MD

Director, Retina Group
Barnet Dulaney Perkins Eye Center
Phoenix, AZ USA

Brandon Johnson, MD

NYC Retina
New York, NY USA

Ahad Mahootchi, MD

Medical Director
The Eye Clinic of Florida
Zephyrhills, FL

Walid Mangal, DO

Florida Vision Institute
Stuart, FL USA

"By incorporating MicroPulse, my injection burden decreases by one-third at a minimum, which is a conservative estimate. The versatility of MicroPulse to treat retinal disorders and glaucoma allows me to provide my patients with a treatment that’s clinically effective, cost effective, and time effective.""MLT is both safe and durable. This therapy can be considered a first-line treatment for glaucoma patients, as well as patients who haven’t seen significant effects from medications."

Jason Friedrichs, MD, MS
Friedrichs Eye
Sycamore, IL USA

"Compared to other lasers, the IQ 532 Laser with the MicroPulse module offers greater versatility because it can also be used for a range of other conditions including diabetic macular edema, proliferative diabetic retinopathy, and retinal tears. I'm comfortable offering MLT to glaucoma patients as a first-line option because of its potential to reduce intraocular pressure without causing tissue damage."

David Gossage, DO, FAOCO, FAAO
Gossage Eye Institute
Hillsdale, MI USA

"The MicroPulse P3 Device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye."

Robert Noecker, MD, MBA
Ophthalmic Consultants of Connecticut
Fairfield, CT USA

"...treatment is less difficult and often takes less time than 532 nm."

Dr. John T. Harriott
Winston-Salem, NC

"The IQ532 Tx Cell Laser System is an invaluable adjunct in my armamentarium for a growing multitude of retinal and choroidal pathologies. In my hands, micropulse laser technology has achieved significant anatomic and functional gains as primary and combination therapy. The TxCell pattern delivery dramatically increases laser application efficiency, as well as patient comfort."

Caesar Luo, MD
Bay Area Retina Associates
Oakland, CA USA

"I have found the MicroPulse P3 Device to be a non-incisional, easy, and safe way to reduce pressure anytime my patients need it, and it is predictable and highly efficacious."

Melissa Toyos, MD
Toyos Clinic
Nashville, TN USA

"MLT is both safe and durable. This therapy can be considered a first-line treatment for glaucoma patients, as well as patients who haven’t seen significant effects from medications."

Ike Ahmed, MD, FRCSC
Prism Eye Institute
Toronto, Ontario, Canada

"I have been impressed that the MicroPulse P3 therapy with the Cyclo G6 Glaucoma Laser can deliver pressure lowering in a broad range of glaucomas, including mild and moderate patients who I want to free from the adverse effects of drops."

Rolando Toyos, MD
Toyos Clinic
Nashville, TN USA

"The visualization of the ciliary body and the surrounding area is impressive. It has really helped me to deliver a patient-specific, targeted CPC treatment with an easy-to-use probe."

Steven Vold, MD
Vold Vision
Fayetteville, AR USA

"You can really consider TSCPC in almost all glaucoma situation, even malignant glaucoma. It is not just relegated to end-stage treatment anymore."

Dr. Jeffrey Kammer
Vanderbilt Eye Institute
Nashville, TN

"TSCPC is a surgery that can be done before or after any other surgery. It is very versatile from that standpoint. "

Nathan Radcliffe, MD

New York Eye Surgery Center
Bronx, NY USA

"Recovery with TSCPC is much more rapid and the postoperative care much less involved than with someone who has had an incisional glaucoma case in a surgical center."

Steven Vold, MD
Vold Vision
Fayetteville, AR USA

Lawrence Morse, MD, PhD

UC Davis
Davis, CA USA

Kishiko Ohkoshi, MD

Professor, Director, Chief Vitreoretinal Surgeon
St. Luke’s International University
Tokyo, Japan

Julia Schulman, MD


NYC Retina
New York, NY USA

Stela Vujosevic, MD

Professor, Medial Retina Specialist
University Hospital Maggiore della Carita
Novara, Italy

Glenn Yiu, MD, PhD

UC Davis
Davis, CA USA

Marco Zarbin, MD, PhD, FACS

Rutgers New Jersey Medical School
Newark, NJ USA

MLT Focused

"I achieved such good results with MLT that I decided to try MicroPulse for treating retinal diseases. I now use it daily to treat many retinal disorders, and MicroPulse allows me to treat patients who I could not have otherwise."

Brandon Philips, MD
Carolina Vision Center
Fayetteville, NC USA

"MLT is versatile in variety of ways: for patients just starting therapy, replacing an eye drop, as an adjunct to an eye drop or to keep them away from incisional surgery."

Nathan Radcliffe, MD
New York Eye Surgery Center
Bronx, NY USA

September 11, 2019: MicroPulse® Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRS 2019 in Paris, France

June 3, 2019: Laser treatment for DME: Still a place at the table

May 1, 2019: Study shows MicroPulse Laser controls IOP after Karatoplasty

April 29, 2019: MicroPulse Laser featured in several Glaucoma and Retina research presentations at Ophthalmic Industry Conferences

April 10, 2019: Meet MicroPulse TSCPC Experts at ASCRS in San Diego on May 4-6, 2019

April 8, 2019: ASCRS Breakfast: MicroPulse TSCPC as a Treatment for Failed MIGS Procedures

April 1, 2019: The Role of Laser for Retinal Vascular Disease in the Anti-VEGF Era

April 1, 2019: MicroPulse featured in multiple abstracts, posters, and presentations at WGC

March 1, 2019: How does wavelength factor into choosing a laser? by Caesar Luo, MD

January 14, 2019: Subthreshold Laser Treatment for Macular Edema by Matteo Forlini, MD

June 25, 2018: Iridex Announces Multiple Studies of MicroPulse® Laser Therapy Published at World Ophthalmology Congress

May 17, 2018: Iridex MicroPulse Technology Featured In Many Scientific Presentations at the European Glaucoma Society Meeting

May 02, 2018: Iridex Announces Dramatic Increase In MicroPulse Visibility at the 2018 ARVO Meeting

September 06, 2017: Iridex Explored on Innovations Breakthrough Series



*Bhagat N, Zarbin M, Mansour S, Chong V, and Cardillo JA. Fovea-friendly MicroPulse Laser. Supplement to Retina Today, May/June 2012
  • logo aa0
  • logo ags
  • logo ascrs
  • logo asrs
  • logo esrs0
  • logo euretina
  • logo LIGHT

Products

Lasers
Delivery Devices
Retina Consumables
Glaucoma Device

Resources

Physician Information
Patient Information
Seminars
Webinars

About Iridex

Overview
Testimonials
Iridex Cares
Newsletters
Contact Us

Company

Investors
Distributors
Careers
News
Events

twitter facebook linkedin youtuber
Copyright ©2003-2026 by Iridex Corporation
Terms of Use    Privacy Statement